Device product
COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.
Z-0401-2021
Product summary
- Event
- Event 86572
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 2051 units
- Official record key
device-enforcement:Z-0401-2021
Official wording
Reason: The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Code information: Model M0068903000, Lots: 100127846, 100127847, 100128709, 100128710, 100129357, 100129614, and 100129615
Distribution pattern: US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV
Derived failure modes
-
Unknown
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.